United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Healthcare Industry News Boston Scientific to take majority stake in Acotec Scientific for $523m Boston Scientific, a US medical device maker, has offered to acquire a stake of up to 65% in… byRaghuram KadariDecember 12, 2022